AU2017201085B2 - Strontium based compositions and formulations for pain, pruritus, and inflammation - Google Patents

Strontium based compositions and formulations for pain, pruritus, and inflammation Download PDF

Info

Publication number
AU2017201085B2
AU2017201085B2 AU2017201085A AU2017201085A AU2017201085B2 AU 2017201085 B2 AU2017201085 B2 AU 2017201085B2 AU 2017201085 A AU2017201085 A AU 2017201085A AU 2017201085 A AU2017201085 A AU 2017201085A AU 2017201085 B2 AU2017201085 B2 AU 2017201085B2
Authority
AU
Australia
Prior art keywords
strontium
formulation
pain
calcium
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2017201085A
Other languages
English (en)
Other versions
AU2017201085A1 (en
Inventor
Siva Gudi
Gary S. Hahn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galleon Labs LLC
Original Assignee
Galleon Labs LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galleon Labs LLC filed Critical Galleon Labs LLC
Publication of AU2017201085A1 publication Critical patent/AU2017201085A1/en
Assigned to GALLEON LABS LLC reassignment GALLEON LABS LLC Request for Assignment Assignors: Cosmederm Bioscience, Inc.
Application granted granted Critical
Publication of AU2017201085B2 publication Critical patent/AU2017201085B2/en
Priority to AU2023222925A priority Critical patent/AU2023222925B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2017201085A 2015-08-21 2017-02-17 Strontium based compositions and formulations for pain, pruritus, and inflammation Active AU2017201085B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2023222925A AU2023222925B2 (en) 2015-08-21 2023-08-31 Strontium based compositions and formulations for pain, pruritus, and inflammation

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562208249P 2015-08-21 2015-08-21
US15/239,171 US20170049807A1 (en) 2015-08-21 2016-08-17 Strontium based compositions and formulations for pain, pruritus, and inflammation
US15/239,171 2016-08-17

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2023222925A Division AU2023222925B2 (en) 2015-08-21 2023-08-31 Strontium based compositions and formulations for pain, pruritus, and inflammation

Publications (2)

Publication Number Publication Date
AU2017201085A1 AU2017201085A1 (en) 2018-03-08
AU2017201085B2 true AU2017201085B2 (en) 2023-08-03

Family

ID=58157450

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2017201085A Active AU2017201085B2 (en) 2015-08-21 2017-02-17 Strontium based compositions and formulations for pain, pruritus, and inflammation
AU2023222925A Active AU2023222925B2 (en) 2015-08-21 2023-08-31 Strontium based compositions and formulations for pain, pruritus, and inflammation

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2023222925A Active AU2023222925B2 (en) 2015-08-21 2023-08-31 Strontium based compositions and formulations for pain, pruritus, and inflammation

Country Status (4)

Country Link
US (1) US20170049807A1 (https=)
JP (2) JP7103752B2 (https=)
AU (2) AU2017201085B2 (https=)
ES (1) ES2925861T3 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3172684B2 (ja) 1996-12-03 2001-06-04 ワイケイケイアーキテクチュラルプロダクツ株式会社 断熱サッシ
EP2827847B1 (en) 2012-03-21 2022-09-14 Galleon Labs LLC Topically administered strontium-containing complexes for treating pain, pruritis and inflammation
US11235002B2 (en) 2015-08-21 2022-02-01 Galleon Labs Llc Strontium based compositions and formulations for pain, pruritus, and inflammation
US20210113496A1 (en) * 2018-04-25 2021-04-22 Horizon Orphan Llc Methods of Treating Excitotoxicity Disorders
WO2022173813A1 (en) * 2021-02-09 2022-08-18 The Regents Of The University Of California Improved bhb-citrate formulations for promoting health
CN113041487B (zh) * 2021-04-23 2025-01-28 佳木斯大学 一种90锶敷贴器治疗装置
CN114452297B (zh) * 2021-12-30 2024-03-12 河南大新药业有限公司 一种治疗皮炎的药物制剂及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0273202A2 (en) * 1986-12-23 1988-07-06 Eugene J. Dr. Van Scott Use of hydroxycarboxylic acids to enhance therapeutic effects of topical compositions for fungal infections and pigmented spots.
WO2013142383A1 (en) * 2012-03-21 2013-09-26 Cosmederm Bioscience, Inc. Topically administered strontium-containing complexes for treating pain, pruritis and inflammation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051609A (en) * 1997-09-09 2000-04-18 Tristrata Technology, Inc. Additives enhancing the effect of therapeutic agents
US5716625A (en) * 1994-12-21 1998-02-10 Cosmederm Technologies Formulations and methods for reducing skin irritation
US6623730B1 (en) 1999-09-14 2003-09-23 Tepha, Inc. Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
NO20014746D0 (no) 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0273202A2 (en) * 1986-12-23 1988-07-06 Eugene J. Dr. Van Scott Use of hydroxycarboxylic acids to enhance therapeutic effects of topical compositions for fungal infections and pigmented spots.
WO2013142383A1 (en) * 2012-03-21 2013-09-26 Cosmederm Bioscience, Inc. Topically administered strontium-containing complexes for treating pain, pruritis and inflammation

Also Published As

Publication number Publication date
AU2017201085A1 (en) 2018-03-08
JP2021119208A (ja) 2021-08-12
ES2925861T3 (es) 2022-10-20
AU2023222925B2 (en) 2025-06-12
BR102017003561A2 (pt) 2018-03-06
JP2018027929A (ja) 2018-02-22
AU2023222925A1 (en) 2023-09-21
JP7103752B2 (ja) 2022-07-20
JP7322094B2 (ja) 2023-08-07
US20170049807A1 (en) 2017-02-23

Similar Documents

Publication Publication Date Title
AU2023222925B2 (en) Strontium based compositions and formulations for pain, pruritus, and inflammation
US11801261B2 (en) Topically administered strontium-containing complexes for treating pain, pruritis and inflammation
WO2016141219A1 (en) Strontium based compositions and formulations for pain, pruritus, and inflammation
US20250099498A1 (en) Strontium based compositions and formulations for pain, pruritus, and inflammation
US20170157169A1 (en) Strontium based compositions and formulations for pain, pruritus, and inflammation
US9480704B2 (en) Topically administered strontium-containing complexes for treating pain, pruritis and inflammation
WO2020132195A1 (en) Strontium based compositions and formulations for pain, pruritus, and inflammation
EP3284462B1 (en) Strontium based compositions and formulations for pain, pruritus, and inflammation
BR102017003561B1 (pt) Composições a base de estrôncio e formulações para dor, prurido e inflamação
HK1204266B (en) Topically administered strontium-containing complexes for treating pain, pruritis and inflammation

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: GALLEON LABS LLC

Free format text: FORMER APPLICANT(S): COSMEDERM BIOSCIENCE, INC.

FGA Letters patent sealed or granted (standard patent)